Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 05.10.2026 FGOV LN IE00BKS2X200   69,469.00 GBP   1,019,082.33   17.304  ...
-

Spherex, Colorado’s Top Cannabis Brand, Acquires Two Colorado Cultivation Facilities to Become Vertically Integrated

DENVER--(BUSINESS WIRE)--Spherex, Colorado’s leading cannabis brand, today announced an agreement to acquire two cultivation facilities from The Cannabist Company (TCC) and its affiliates, The Green Solution (TGS) and Rocky Mountain Tillage (RMT), as part of TCC’s ongoing business restructuring. The transaction represents Spherex’s first acquisition and a significant expansion of the company’s operations. The expansion includes a Denver-area indoor cultivation facility and an outdoor cultivatio...
-

International Bancshares Corporation to Transfer Primary Listing to Texas Stock Exchange

LAREDO, Texas--(BUSINESS WIRE)--International Bancshares Corporation (NASDAQ: IBOC) announced plan to transfer from Nasdaq Stock Market (“Nasdaq”) to Texas Stock Exchange (“TXSE”)....
-

USCIS Approves EB-5 Investment Offering for First Solar-Powered Cobalt Processing Facility in U.S.

YUMA, Ariz.--(BUSINESS WIRE)--EVelution Energy LLC ("EVelution Energy" or the “Company”), a U.S. critical minerals company developing America's first commercial-scale, solar-powered cobalt sulfate and cobalt metal processing facility, announced that on September 30, 2026, the United States Citizenship and Immigration Services ("USCIS") approved the project’s EB-5 investment offering, which is expected to support up to approximately US$64.8 million in subordinated project financing. The EB-5 Imm...
-

DemeRx Appoints Ibogaine Pioneer Juan Sanchez-Ramos to Scientific Advisory Board

MIAMI--(BUSINESS WIRE)--DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced the appointment of Juan R. Sanchez-Ramos, M.D., Ph.D., to its Scientific Advisory Board. A neurologist and clinician-scientist whose career has spanned addiction, movement disorders, and neurodegenerative diseases, Dr. Sanchez-Ramos was an early leader in the clinical investigation of ibogaine and a scientific collaborator of DemeRx founder and CEO D...
-

MassMutual Enhances Permanent Life Insurance Portfolio With Launch of Whole Life Guard 10 Pay and Whole Life 95

SPRINGFIELD, Mass.--(BUSINESS WIRE)--MassMutual today announced the introduction of Whole Life Guard 10 Pay and Whole Life 95, two new participating whole life insurance policies designed to help people address a range of long-term financial protection and planning needs. The additions further strengthen MassMutual's whole life insurance portfolio, providing greater choice and flexibility with permanent life insurance coverage. Both policies provide: Lifelong protection Cash value accumulation,...
-

Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company addressing drug resistance in cancer, today announced positive interim efficacy data from its ongoing Phase 2 clinical trial evaluating ENV-105 (carotuximab) in combination with apalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC). The interim analysis demonstrated a statistically significant difference in progression-free survival (PFS) between all...
-

Energy Transfer to Acquire Vaquero Midstream in a $2.625 Billion Transaction

DALLAS--(BUSINESS WIRE)--Energy Transfer LP (Texas Stock Exchange, TXSE: ET) and Vaquero Midstream LLC (Vaquero) announced today that the parties have entered into a definitive agreement pursuant to which Energy Transfer will acquire Vaquero in a bolt-on transaction valued at approximately $2.625 billion. The transaction consideration will consist of $1.95 billion in cash and approximately 33.3 million newly issued Energy Transfer common units. The acquisition is expected to close in the 4th qu...
-

New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1

PARSIPPANY, N.J.--(BUSINESS WIRE)--Drug-resistant heartworm is a growing concern for veterinarians and pet owners as resistant heartworm populations emerge. New research shows that not all heartworm preventives perform equally against these resistant isolates. Macrocyclic lactone (ML) resistance means some heartworm isolates are less sensitive to the drug class used in today’s heartworm disease preventives. As ML resistance continues to challenge heartworm prevention, veterinarians need data th...
-

Vecima Broadband Solutions Recognized in Lightwave’s 2026 Diamond Technology Reviews

VICTORIA, British Columbia--(BUSINESS WIRE)--Vecima announces that three solutions in its Entra broadband access portfolio have received 2026 Diamond Technology Review recognition from Lightwave....